Covered recipient · General Payments record
YAKOV ISAKOV
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$9,036.66
- Reported across 247 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $779.44 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $681.08 | 16 |
| Biogen, Inc. | $71.13 | 1 |
| Medtronic, Inc. | $27.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.56 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971285 | CMS |
| ABBVIE INC. | $104.00 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971287 | CMS |
| ABBVIE INC. | $34.86 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971289 | CMS |
| ABBVIE INC. | $19.44 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971291 | CMS |
| ABBVIE INC. | $1.59 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971293 | CMS |
| ABBVIE INC. | $34.93 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971295 | CMS |
| ABBVIE INC. | $7.03 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971297 | CMS |
| ABBVIE INC. | $31.51 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971299 | CMS |
| ABBVIE INC. | $31.79 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971301 | CMS |
| ABBVIE INC. | $102.50 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971303 | CMS |
| ABBVIE INC. | $110.50 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971305 | CMS |
| ABBVIE INC. | $26.06 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971307 | CMS |
| ABBVIE INC. | $8.33 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971309 | CMS |
| ABBVIE INC. | $125.00 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971311 | CMS |
| ABBVIE INC. | $6.85 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971313 | CMS |
| ABBVIE INC. | $5.13 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103971315 | CMS |
| Biogen, Inc. | $71.13 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104817557 | CMS |
| Medtronic, Inc. | $27.23 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117175848 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.